Assyro AI
Free, no spam, unsubscribe anytime

Regulatory intelligence, delivered weekly

Stay ahead of FDA, EMA, and Health Canada changes. Get actionable insights on submissions, eCTD validation, and compliance without digging through Federal Register notices yourself.

Unsubscribe in one click. No spam, ever.

What you'll get every week

Curated by regulatory professionals, not a content farm.

Regulatory Updates

FDA, EMA, Health Canada rule changes that affect your submissions.

eCTD Best Practices

Validation tips, sequence structuring, and common rejection patterns.

Global Intelligence

Cross-jurisdiction insights for multi-market submissions.

Industry Trends

AI in regulatory, emerging guidelines, and operational benchmarks.

Compliance Alerts

Deadline reminders, PDUFA dates, and enforcement actions.

Product Updates

New Assyro features, workflows, and platform improvements.

Recent highlights

A sample of what recent issues covered.

How ICH Q12 impacts your post-approval change strategy
5 eCTD validation errors that cause 80% of rejections
FDA vs EMA: diverging expectations for Module 2.3
Building a submission readiness checklist your team will use

Stop chasing regulatory updates

Let us bring the signal to you. One email per week, no fluff.